Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

PURPOSE: In studies of diffuse large B-cell lymphoma, positron emission tomography with [(18)F]fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has demonstrated prognostic significance. However, some patients treated with immunochemotherapy experience a favorable long-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Moskowitz, Craig H., Schöder, Heiko, Teruya-Feldstein, Julie, Sima, Camelia, Iasonos, Alexia, Portlock, Carol S., Straus, David, Noy, Ariela, Palomba, Maria L., O'Connor, Owen A., Horwitz, Steven, Weaver, Sarah A., Meikle, Jessica L., Filippa, Daniel A., Caravelli, James F., Hamlin, Paul A., Zelenetz, Andrew D.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651601/
https://ncbi.nlm.nih.gov/pubmed/20212248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.5942
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki